Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase

Xuan Wang; Yunsheng Li; Yanrong Qian; Yanyang Cao; Pratik Shriwas; Haiyun Zhang; Xiaozhuo Chen

doi:10.18632/oncotarget.21231

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase

Xuan Wang, Yunsheng Li, Yanrong Qian, Yanyang Cao, Pratik Shriwas, Haiyun Zhang and Xiaozhuo Chen _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:87860-87877. https://doi.org/10.18632/oncotarget.21231

Metrics: PDF 1889 views | HTML 3748 views | ?

Abstract

Xuan Wang1,2,3, Yunsheng Li3, Yanrong Qian3, Yanyang Cao1,2,3, Pratik Shriwas1,2,3, Haiyun Zhang1,2,3 and Xiaozhuo Chen1,2,3,4,5

1Department of Biological Sciences, Ohio University, Athens, Ohio 45701, USA

2Interdisciplinary Graduate Program in Molecular and Cellular Biology, Ohio University, Athens, Ohio 45701, USA

3The Edison Biotechnology Institute, Ohio University, Athens, Ohio 45701, USA

4Department of Chemistry and Biochemistry, Ohio University, Athens, Ohio 45701, USA

5Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio 45701, USA

Correspondence to:

Xiaozhuo Chen, email: [email protected]

Keywords: the Warburg effect, tumor microenvironment, cancer metabolism, PDGFR, sunitinib

Received: June 12, 2017 Accepted: August 16, 2017 Published: September 23, 2017

ABSTRACT

Cancer cells are able to uptake extracellular ATP (eATP) via macropinocytosis to elevate intracellular ATP (iATP) levels, enhancing their survival in drug treatment. However, the involved drug resistance mechanisms are unknown. Here we investigated the roles of eATP as either an energy or a phosphorylating molecule in general drug resistance mediated by ATP internalization and iATP elevation. We report that eATP increased iATP levels and promoted drug resistance to various tyrosine kinase inhibitors (TKIs) and chemo-drugs in human cancer cell lines of five cancer types. In A549 lung cancer cells, the resistance was downregulated by macropinocytosis inhibition or siRNA knockdown of PAK1, an essential macropinocytosis enzyme. The elevated iATP upregulated the efflux activity of ABC transporters in A549 and SK-Hep-1 cells as well as phosphorylation of PDGFRα and proteins in the PDGFR-mediated Akt-mTOR and Raf-MEK signaling pathways in A549 cells. Similar phosphorylation upregulations were found in A549 tumors. These results demonstrate that eATP induces different types of drug resistance by eATP internalization and iATP elevation, implicating the ATP-rich tumor microenvironment in cancer drug resistance, expanding our understanding of the roles of eATP in the Warburg effect and offering new anticancer drug resistance targets.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21231

Publication Alerts

Research Papers:

Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase

Abstract